Dexmedetomidine for awake fiberoptic intubation in a parturient with spinal muscular atrophy type III for cesarean delivery

M. M. Neumann, M. B. Davio, M. R. Macknet, Richard Lee Applegate

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Spinal muscular atrophy in pregnancy is rare and poses multiple problems for the anesthesiologist. The effects of dexmedetomidine on a parturient with spinal muscular atrophy have not previously been reported. There are also no in vivo data on placental transfer of dexmedetomidine and its effects on a human neonate. We report the hemodynamic, respiratory and sedative effects of dexmedetomidine on a parturient and neonate when used for awake fiberoptic intubation before cesarean section. A 35-year-old, gravida 4 para 0 aborta 3, 41-kg parturient at 35 weeks of gestation with spinal muscular atrophy presented for cesarean section. Dexmedetomidine was administered intravenously, total dose 1.84 μg/kg over 38 minutes, followed by fiberoptic endotracheal intubation. Dexmedetomidine was then discontinued and general anesthesia was induced. The baby was delivered 68 minutes after the dexmedetomidine infusion was discontinued at which time blood samples were obtained for measurement of dexmedetomidine. During administration of dexmedetomidine, maternal heart rate, blood pressure and oxygen saturation remained stable. Apgar scores at 1 and 5 min were 6 and 8. The fetal concentration of dexmedetomidine (540 pg/mL) indicates significant placental transfer, but significant adverse neonatal effects were not observed. Dexmedetomidine alone provided adequate sedation for awake intubation without respiratory compromise in this patient.

Original languageEnglish (US)
Pages (from-to)403-407
Number of pages5
JournalInternational Journal of Obstetric Anesthesia
Volume18
Issue number4
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Spinal Muscular Atrophies of Childhood
Dexmedetomidine
Intubation
Parturition
Spinal Muscular Atrophy
Cesarean Section
Newborn Infant
Pregnancy
Intratracheal Intubation
Apgar Score
Hypnotics and Sedatives
General Anesthesia
Heart Rate
Hemodynamics
Mothers

Keywords

  • Awake fiberoptic intubation
  • Cesarean section
  • Dexmedetomidine
  • General anesthesia
  • Pregnancy
  • Spinal muscular atrophy

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Obstetrics and Gynecology

Cite this

Dexmedetomidine for awake fiberoptic intubation in a parturient with spinal muscular atrophy type III for cesarean delivery. / Neumann, M. M.; Davio, M. B.; Macknet, M. R.; Applegate, Richard Lee.

In: International Journal of Obstetric Anesthesia, Vol. 18, No. 4, 10.2009, p. 403-407.

Research output: Contribution to journalArticle

@article{1c353f56a6514fddae738f0bd9b12fbb,
title = "Dexmedetomidine for awake fiberoptic intubation in a parturient with spinal muscular atrophy type III for cesarean delivery",
abstract = "Spinal muscular atrophy in pregnancy is rare and poses multiple problems for the anesthesiologist. The effects of dexmedetomidine on a parturient with spinal muscular atrophy have not previously been reported. There are also no in vivo data on placental transfer of dexmedetomidine and its effects on a human neonate. We report the hemodynamic, respiratory and sedative effects of dexmedetomidine on a parturient and neonate when used for awake fiberoptic intubation before cesarean section. A 35-year-old, gravida 4 para 0 aborta 3, 41-kg parturient at 35 weeks of gestation with spinal muscular atrophy presented for cesarean section. Dexmedetomidine was administered intravenously, total dose 1.84 μg/kg over 38 minutes, followed by fiberoptic endotracheal intubation. Dexmedetomidine was then discontinued and general anesthesia was induced. The baby was delivered 68 minutes after the dexmedetomidine infusion was discontinued at which time blood samples were obtained for measurement of dexmedetomidine. During administration of dexmedetomidine, maternal heart rate, blood pressure and oxygen saturation remained stable. Apgar scores at 1 and 5 min were 6 and 8. The fetal concentration of dexmedetomidine (540 pg/mL) indicates significant placental transfer, but significant adverse neonatal effects were not observed. Dexmedetomidine alone provided adequate sedation for awake intubation without respiratory compromise in this patient.",
keywords = "Awake fiberoptic intubation, Cesarean section, Dexmedetomidine, General anesthesia, Pregnancy, Spinal muscular atrophy",
author = "Neumann, {M. M.} and Davio, {M. B.} and Macknet, {M. R.} and Applegate, {Richard Lee}",
year = "2009",
month = "10",
doi = "10.1016/j.ijoa.2009.05.002",
language = "English (US)",
volume = "18",
pages = "403--407",
journal = "International Journal of Obstetric Anesthesia",
issn = "0959-289X",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Dexmedetomidine for awake fiberoptic intubation in a parturient with spinal muscular atrophy type III for cesarean delivery

AU - Neumann, M. M.

AU - Davio, M. B.

AU - Macknet, M. R.

AU - Applegate, Richard Lee

PY - 2009/10

Y1 - 2009/10

N2 - Spinal muscular atrophy in pregnancy is rare and poses multiple problems for the anesthesiologist. The effects of dexmedetomidine on a parturient with spinal muscular atrophy have not previously been reported. There are also no in vivo data on placental transfer of dexmedetomidine and its effects on a human neonate. We report the hemodynamic, respiratory and sedative effects of dexmedetomidine on a parturient and neonate when used for awake fiberoptic intubation before cesarean section. A 35-year-old, gravida 4 para 0 aborta 3, 41-kg parturient at 35 weeks of gestation with spinal muscular atrophy presented for cesarean section. Dexmedetomidine was administered intravenously, total dose 1.84 μg/kg over 38 minutes, followed by fiberoptic endotracheal intubation. Dexmedetomidine was then discontinued and general anesthesia was induced. The baby was delivered 68 minutes after the dexmedetomidine infusion was discontinued at which time blood samples were obtained for measurement of dexmedetomidine. During administration of dexmedetomidine, maternal heart rate, blood pressure and oxygen saturation remained stable. Apgar scores at 1 and 5 min were 6 and 8. The fetal concentration of dexmedetomidine (540 pg/mL) indicates significant placental transfer, but significant adverse neonatal effects were not observed. Dexmedetomidine alone provided adequate sedation for awake intubation without respiratory compromise in this patient.

AB - Spinal muscular atrophy in pregnancy is rare and poses multiple problems for the anesthesiologist. The effects of dexmedetomidine on a parturient with spinal muscular atrophy have not previously been reported. There are also no in vivo data on placental transfer of dexmedetomidine and its effects on a human neonate. We report the hemodynamic, respiratory and sedative effects of dexmedetomidine on a parturient and neonate when used for awake fiberoptic intubation before cesarean section. A 35-year-old, gravida 4 para 0 aborta 3, 41-kg parturient at 35 weeks of gestation with spinal muscular atrophy presented for cesarean section. Dexmedetomidine was administered intravenously, total dose 1.84 μg/kg over 38 minutes, followed by fiberoptic endotracheal intubation. Dexmedetomidine was then discontinued and general anesthesia was induced. The baby was delivered 68 minutes after the dexmedetomidine infusion was discontinued at which time blood samples were obtained for measurement of dexmedetomidine. During administration of dexmedetomidine, maternal heart rate, blood pressure and oxygen saturation remained stable. Apgar scores at 1 and 5 min were 6 and 8. The fetal concentration of dexmedetomidine (540 pg/mL) indicates significant placental transfer, but significant adverse neonatal effects were not observed. Dexmedetomidine alone provided adequate sedation for awake intubation without respiratory compromise in this patient.

KW - Awake fiberoptic intubation

KW - Cesarean section

KW - Dexmedetomidine

KW - General anesthesia

KW - Pregnancy

KW - Spinal muscular atrophy

UR - http://www.scopus.com/inward/record.url?scp=70349298302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349298302&partnerID=8YFLogxK

U2 - 10.1016/j.ijoa.2009.05.002

DO - 10.1016/j.ijoa.2009.05.002

M3 - Article

C2 - 19733055

AN - SCOPUS:70349298302

VL - 18

SP - 403

EP - 407

JO - International Journal of Obstetric Anesthesia

JF - International Journal of Obstetric Anesthesia

SN - 0959-289X

IS - 4

ER -